Latest Articles
Olabimpe Fapohunda, Ondo South-West LCDA empower women, educate young girls on health risks - Tribune Online
Olabimpe Fapohunda, Ondo South-West LCDA empower women, educate young girls on health risks Tribune Online
Published: Nov. 13, 2024, 5:28 p.m.
Similar outcomes from A-repair vs paravaginal repair reported - Contemporary Obgyn
Similar outcomes from A-repair vs paravaginal repair reported Contemporary Obgyn
Published: Nov. 11, 2024, 7:04 p.m.
Increasing ondansetron use reported against NVP in the United States - Contemporary Obgyn
Increasing ondansetron use reported against NVP in the United States Contemporary Obgyn
Published: Oct. 29, 2024, 3:06 p.m.
Study finds high rates of incidental MRI findings in endometriosis cases - Contemporary Obgyn
Study finds high rates of incidental MRI findings in endometriosis cases Contemporary Obgyn
Published: Oct. 29, 2024, 1:04 p.m.
Understanding cardiovascular risk factors in women - Contemporary Obgyn
Understanding cardiovascular risk factors in women Contemporary Obgyn
Published: Oct. 28, 2024, 8:11 p.m.
HP-hMG stimulation reduces OHSS risk in high responder patients - Contemporary Obgyn
HP-hMG stimulation reduces OHSS risk in high responder patients Contemporary Obgyn
Published: Oct. 25, 2024, 6:50 p.m.
Contemporary OB/GYN week in review: FLOBLOK update, breast cancer management, and more - Contemporary Obgyn
Contemporary OB/GYN week in review: FLOBLOK update, breast cancer management, and more Contemporary Obgyn
Published: Oct. 25, 2024, 6:45 p.m.
Racial disparities in high-risk endometrial subtype diagnoses reported - Contemporary Obgyn
Racial disparities in high-risk endometrial subtype diagnoses reported Contemporary Obgyn
Published: Oct. 24, 2024, 6:26 p.m.
Association reported between ART and imprinting disorders - Contemporary Obgyn
Association reported between ART and imprinting disorders Contemporary Obgyn
Published: Oct. 23, 2024, 5:39 p.m.
Atavistik Bio Presents Preclinical Data on Precision Oncology Development Candidate, ATV-1601, a Selective Allosteric AKT1 E17K Small Molecule Inhibitor, at EORTC-NCI-AACR Symposium - The Manila Times
Atavistik Bio Presents Preclinical Data on Precision Oncology Development Candidate, ATV-1601, a Selective Allosteric AKT1 E17K Small Molecule Inhibitor, at EORTC-NCI-AACR Symposium The Manila Times
Published: Oct. 23, 2024, 10:06 a.m.
Link copied to clipboard!